Tylenol Manufacturer's Stock Drops Amid HHS Autism Report Plans

Shares of Kenvue, the parent company of Tylenol manufacturer McNeil Consumer Healthcare, experienced a significant decline following reports about an upcoming Health and Human Services (HHS) announcement. According to The Wall Street Journal, HHS Secretary Robert F. Kennedy Jr. is preparing to release a report this month examining potential causes of autism. The report is expected to discuss possible connections between autism and both Tylenol use during pregnancy and low folate levels, according to sources familiar with the matter.